Tokio Marine Asset Management Co. Ltd. Sells 87 Shares of Align Technology, Inc. (NASDAQ:ALGN)

Tokio Marine Asset Management Co. Ltd. trimmed its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 3.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,181 shares of the medical equipment provider’s stock after selling 87 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Align Technology were worth $555,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of ALGN. Mather Group LLC. increased its holdings in shares of Align Technology by 52.5% during the 2nd quarter. Mather Group LLC. now owns 122 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 42 shares during the last quarter. Quarry LP boosted its position in Align Technology by 53.0% during the second quarter. Quarry LP now owns 127 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 44 shares during the period. Crewe Advisors LLC grew its holdings in Align Technology by 36.8% during the second quarter. Crewe Advisors LLC now owns 171 shares of the medical equipment provider’s stock valued at $41,000 after purchasing an additional 46 shares during the last quarter. Daiwa Securities Group Inc. raised its position in shares of Align Technology by 0.6% in the second quarter. Daiwa Securities Group Inc. now owns 8,876 shares of the medical equipment provider’s stock valued at $2,143,000 after purchasing an additional 54 shares during the period. Finally, Lake Street Advisors Group LLC raised its position in shares of Align Technology by 5.6% in the third quarter. Lake Street Advisors Group LLC now owns 1,042 shares of the medical equipment provider’s stock valued at $265,000 after purchasing an additional 55 shares during the period. 88.43% of the stock is currently owned by institutional investors.

Align Technology Trading Up 0.9 %

Shares of NASDAQ:ALGN opened at $223.69 on Friday. The firm has a market capitalization of $16.70 billion, a PE ratio of 38.17, a PEG ratio of 5.57 and a beta of 1.65. Align Technology, Inc. has a 1-year low of $196.09 and a 1-year high of $335.40. The business’s 50 day moving average is $228.85 and its 200-day moving average is $240.23.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, October 23rd. The medical equipment provider reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $2.31 by $0.04. The firm had revenue of $977.87 million for the quarter, compared to the consensus estimate of $990.05 million. Align Technology had a net margin of 11.15% and a return on equity of 13.99%. The business’s revenue was up 1.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.62 earnings per share. On average, sell-side analysts predict that Align Technology, Inc. will post 7.45 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on ALGN shares. Needham & Company LLC reiterated a “hold” rating on shares of Align Technology in a research note on Monday, November 4th. Evercore ISI lowered their price target on Align Technology from $270.00 to $250.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Morgan Stanley dropped their price objective on Align Technology from $310.00 to $280.00 and set an “overweight” rating on the stock in a research note on Thursday, October 24th. StockNews.com upgraded Align Technology from a “hold” rating to a “buy” rating in a research note on Thursday, September 19th. Finally, Stifel Nicolaus dropped their price target on Align Technology from $285.00 to $275.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $276.38.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.